Skip to main content

Table 1 Comparison of clinicopathological features among men who underwent a contemporary multicore prostate biopsy

From: Clinical importance of the antibiotic regimen in transrectal ultrasound-guided biopsy: quinolone versus cephalosporin

Variable

Entire cohort

 Number of patients

5215

 Median age (years)(IQR)

66 (60–71)

 Mean BMI (kg/m2)

24.3 ± 2.7

 Diabetes mellitus (%)

742 (14.2)

 Median PSA (ng/mL)(IQR)

6.4 (4.3–10.5)

 Mean prostate volume (mL)

45.6 ± 22.5

  IPSS (%)

   Mild

1835 (35.2)

   Moderate

2439 (46.8)

   Severe

941 (18.0)

  Year of prostate biopsy (%)

   2003–2007

2348 (45.0)

   2008–2013

2867 (55.0)

  Antibiotic prophylaxis (%)

   Quinolone

990 (19.0)

   Third-generation cephalosporin

4225 (81.0)

  Number of biopsy cores (%)

    ≤ 12

3470 (66.5)

    ≥ 13

1745 (33.5)

  Pathologic diagnosis after biopsy (%)

   Carcinoma

1780 (31.4)

   Prostatitis

438 (8.4)

   Others

2.997 (57.5)

   Admission for infectious complications (%)

28 (0.54)